Showing results (1701-1710 of 3,196) with videos related to

Sort By:
Pageof 320
Translational Oncology|April 22, 2022
The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective studyYilin Yu, Haishan Wu, Jianjian Qiu, et al.
Translational Oncology|July 26, 2022
CEACAM5 targeted by miR-498 promotes cell proliferation, migration and epithelial to mesenchymal transition in gastric cancerLiang Zhang, Chao Zhang, Nian Liu
Translational Oncology|April 23, 2022
Therapeutic approaches for the treatment of head and neck squamous cell carcinoma-An update on clinical trialsBharat Goel, Anoop Kumar Tiwari, Rajeev Kumar Pandey, et al.
Translational Oncology|June 18, 2019
Telomere Maintenance-Associated PML Is a Potential Specific Therapeutic Target of Human Colorectal CancerPeng Gong, Hua Wang, Jingsong Zhang, et al.
Translational Oncology|June 10, 2019
Knockdown of Lumican Inhibits Proliferation and Migration of Bladder CancerWeipu Mao, Ming Luo, Xin Huang, et al.
Translational Oncology|July 5, 2019
Circulating Mitochondrial DNA is Linked to Progression and Prognosis of Epithelial Ovarian CancerXiaodan Meng, Heidi Schwarzenbach, Yifeng Yang, et al.
Translational Oncology|June 29, 2019
Preclinical Pharmacokinetic and Safety Studies of Copper-Diacetyl-Bis(N4-Methylthiosemicarbazone) (Cu-ATSM): Translational Studies for Internal RadiotherapyHiroki Matsumoto, Yukie Yoshii, Atsumi Baden, et al.
Translational Oncology|February 19, 2022
Comment on 'Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression' by Chen et al.'"Chi-Wei Chen
Translational Oncology|February 15, 2022
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticlesMohammad-Javad Sanaei, Sara Razi, Atieh Pourbagheri-Sigaroodi, et al.
Translational Oncology|February 10, 2022
Comparative study of radiomics, tumor morphology, and clinicopathological factors in predicting overall survival of patients with rectal cancer before surgeryZhou Chuanji, Wang Zheng, Lai Shaolv, et al.
Pageof 320